The capacity to appoint a proxy and the possibility of concurrent proxy directives

Behavioral Sciences and the Law

Volumn 24, Issue 4, 2006, Pages 469-478

  Kim, Scott Y H ^a   Appelbaum, Paul S ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CONFERENCE PAPER; CUSTODY; DEGENERATIVE DISEASE; DEMENTIA; ETHICS; HUMAN; INFORMED CONSENT; INTERVIEW; MEDICAL DECISION MAKING;

ADVANCE DIRECTIVES; AGED; COGNITION DISORDERS; DECISION MAKING; HUMANS; MENTAL COMPETENCY; NEURODEGENERATIVE DISEASES; PILOT PROJECTS; PROXY; UNITED STATES;

EID: 33646704926     PISSN: 07353936     EISSN: 10990798     Source Type: Journal    
DOI: 10.1002/bsl.702     Document Type: Conference Paper

References (35)

1. AD 2000. (2004). Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): Randomised double-blind trial. The Lancet, 363, 2105-2115.
2. Buchanan, A. E., & Brock, D. W. (1989). Deciding for others: The ethics of surrogate decision making. New York: Cambridge University Press.
3. Dresser, R. (2001). Advance directives in dementia research. IRB Ethics and Human Research, 23, 1-6.
4. Dukoff, R., & Sunderland, T. (1997). Durable power of attorney and informed consent with Alzheimer's disease patients: A clinical study. American Journal of Psychiatry, 154, 1070-1075.
5. Etchells, E., Darzins, P., Silberfeld, M., Singer, P. A., McKenny, J., Naglie, G., Katz, M., Guyatt, G. H., Molloy, D. W., & Strang, D. (1999). Assessment of patient capacity to consent to treatment. Journal of General Internal Medicine, 14, 27-34.
6. Expert Panel Report to the National Institutes of Health. (1998). Research involving individuals with questionable capacity to consent: Ethical issues and practical considerations for Institutional Review Boards.
7. Fagerlin, A., & Schneider, C. E. (2004). Enough: The failure of the living will. Hastings Center Report, 34, 30-42.
8. Grisso, T. (2003). Evaluating competencies, 2nd ed. New York: Kluwer-Plenum.
9. Grisso, T., & Appelbaum, P. S. (1998). Assessing competence to consent to treatment: A guide for physicians and other health professionals. New York: Oxford University Press.
10. Grisso, T., Appelbaum, P. S., Mulvey, E. P., & Fletcher, K. (1995). The MacArthur Treatment Competence Study. II: Measures of abilities related to competence to consent to treatment. Law and Human Behavior, 19, 127-148.
11. Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003). Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Archives of Neurology, 60, 1119-1122.
12. High, D. M. (1993). Advancing research with Alzheimer disease subjects: Investigators' perceptions and ethical issues. Alzheimer Disease and Associated Disorders, 7, 165-178.
13. Karlawish, J., Casarett, D., Klocinski, J., & Sankar, P. (2001). How do AD patients and their caregivers decide whether to enroll in a clinical trial? Neurology, 56, 789-792.
14. Karlawish, J. H. T., Knopman, D., Clark, C. M., Morris, J. C., Marson, D., Whitehouse, P. J., & Kawas, C. (2002). Informed consent for Alzheimer's Disease clinical trials: A survey of clinical investigators. IRB: Ethics and Human Research, 24, 1-5.
15. Kim, S. Y. H., Appelbaum, P. S., Jeste, D. V., & Olin, J. T. (2004). Proxy and surrogate consent in geriatric neuropsychiatric research: Update and recommendations. American Journal of Psychiatry, 161, 797-806.
16. Kim, S. Y. H., Caine, E. D., Currier, G. W., Leibovici, A., & Ryan, J. M. (2001). Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research. American Journal of Psychiatry, 158, 712-717.
17. Kim, S. Y. H., Cox, C., & Caine, E. D. (2002a). Impaired decision-making ability and willingness to participate in research in persons with Alzheimer's disease. American Journal of Psychiatry, 159, 797-802.
18. Kim, S. Y. H., Karlawish, J. H. T., & Caine, E. D. (2002b). Current state of research on decision-making competence of cognitively impaired elderly persons. American Journal of Geriatric Psychiatry, 10, 151-165.
19. Levine, R. (1986). Ethics and regulation of clinical research, 2nd ed. New Haven, CT: Yale University Press.
20. Lidz, C. W., & Appelbaum, P. S. (2002). The therapeutic misconception: Problems and solutions. Medical Care, 40, Supplement V.
21. Marson, D. C., Chatterjee, A., Ingram, K. K., & Harrell, L. E. (1996). Toward a neurologic model of competency: Cognitive predictors of capacity to consent in Alzheimer's disease using three different legal standards. Neurology, 46, 666-672.
22. Marson, D. C., Cody, H. A., Ingram, K. K., & Harrell, L. E. (1995a). Neuropsychological predictors of competency in Alzheimer's disease using a rational reasons legal standard [comment]. Archives of Neurology, 52, 955-959.
23. Marson, D. C., Ingram, K. K., Cody, H. A., & Harrell, L. E. (1995b). Assessing the competency of patients with Alzheimer's disease under different legal standards. A prototype instrument. Archives of Neurology, 52, 949-954.
24. Marson, D. C., McInturff, B., Hawkins, L., Bartolucci, A., & Harrell, L. E. (1997). Consistency of physician judgments of capacity to consent in mild Alzheimer's disease. Journal of the American Geriatric Society, 45, 453-457.
25. Mezey, M., Teresi, J., Ramsey, G., Mitty, E., & Bobrowitz, T. (2000). Decision-making capacity to execute a health care proxy: development and testing of guidelines. Journal of the American Geriatric Society, 48, 179-187.
26. National Bioethics Advisory Commission. (1998). Research involving persons with mental disorders that may affect decisionmaking capacity (Vol. 1). Rockville, MD: Author.
27. Orgogozo, J. M., Gilman, S., Dartigues, J. F., Laurent, B., Puel, M., Kirby, L. C., Jouanny, P., Dubois, B., Eisner, L., Flitman, S., Michel, B. F., Boada, M., Frank, A., & Hock, C. (2003). Subacute meningoencephalitis in a subset of patients with AD after Ab42 immunization. Neurology, 61, 46-54.
28. Sachs, G. A. (1994). Advance consent for dementia research. Alzheimer Disease and Associated Disorders, 8(Suppl. 4), 19-27.
29. Silverberg, G. D., Levinthal, E., Sullivan, E. V., Bloch, D. A., Chang, S. D., Leverenz, J., Flitman, S., Winn, R., Marciano, F., Saul, T., Huhn, S., Mayo, M., & McGuire, D. (2002). Assessment of low-flow CSF drainage as a treatment for AD: Results of a randomized pilot study [comment]. Neurology, 59, 1139-1145.
30. Sugarman, J., Cain, C., Wallace, R., & Welsh-Bohmer, K. A. (2001). How proxies make decisions about research for patients with Alzheimer's disease. Journal of the American Geriatric Society, 49, 1110-1119.
31. Sunderland, T., Linker, G., Mirza, N., Putnam, K. T., Friedman, D. L., Kimmel, L. H., Bergeson, J., Manetti, G. J., Zimmermann, M., Tang, B., Bartko, J. J., & Cohen, R. M. (2003). Decreased β-amyloid 1-42 and increased Tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA, 289, 2094-2103.
32. Tuszynski, M. H., Thal, L., Pay, M., Salmon, D. P., Hoi, S., Bakay, R., Patel, P., Blesch, A., Vahlsing, H. L., Ho, G., Tong, G., Potkin, S. G., Fallon, J., Hansen, L., Mufson, E. J., Kordower, J. H., Gall, C., & Conner, J. (2005). A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nature Medicine, 11, 551-555.
33. Wendler, D., Martinez, R. A., Fairclough, D., Sunderland, T., & Emanuel, E. (2002). Views of potential subjects toward proposed regulations for clinical research with adults unable to consent. American Journal of Psychiatry, 159, 585-591.
34. Wendler, D., & Prasad, K. (2001). Core safeguards for clinical research with adults who are unable to consent. Annals of Internal Medicine, 135, 514-523.
35. Wirshing, D. A., Wirshing, W. C., Marder, S. R., Liberman, R. P., & Mintz, J. (1998). Informed consent: Assesment of comprehension. American Journal of Psychiatry, 155, 1508-1511.